Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Poland
· Delayed Price · Currency is PLN 19.30
0.00 (0.00%)
May 2, 2025, 9:25 AM CET
Centrum Medyczne ENEL-MED Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 735.59 | 618.55 | 494.9 | 441.14 | 399.8 | Upgrade
|
| Revenue | 735.59 | 618.55 | 494.9 | 441.14 | 399.8 | Upgrade
|
Revenue Growth (YoY) | 18.92% | 24.98% | 12.19% | 10.34% | -4.28% | Upgrade
|
Cost of Revenue | 677.09 | 592.59 | 484.02 | 419 | 369.5 | Upgrade
|
Gross Profit | 58.51 | 25.96 | 10.88 | 22.14 | 30.3 | Upgrade
|
Selling, General & Admin | 35.54 | 33.51 | 37.12 | 23.82 | 20.23 | Upgrade
|
Other Operating Expenses | -4.98 | -9.11 | -6.54 | -3.73 | -3.3 | Upgrade
|
Operating Expenses | 30.56 | 24.4 | 30.58 | 20.09 | 16.93 | Upgrade
|
Operating Income | 27.95 | 1.56 | -19.7 | 2.06 | 13.37 | Upgrade
|
Interest Expense | -12.47 | -9.9 | -5.82 | -5.33 | -7.52 | Upgrade
|
Interest & Investment Income | - | 1.82 | 2.46 | 1.64 | 1.09 | Upgrade
|
Currency Exchange Gain (Loss) | - | 16.65 | -2.83 | 0.61 | -9.98 | Upgrade
|
Other Non Operating Income (Expenses) | 3.67 | -0.02 | -0.01 | -0.01 | -0.03 | Upgrade
|
EBT Excluding Unusual Items | 19.14 | 10.11 | -25.89 | -1.03 | -3.07 | Upgrade
|
Gain (Loss) on Sale of Investments | - | -0.04 | -0.77 | - | -3.24 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -3.34 | -1.28 | -0.1 | -0.97 | Upgrade
|
Legal Settlements | - | -0.04 | - | -0.02 | -0 | Upgrade
|
Other Unusual Items | - | 3.13 | - | 1.24 | 2.8 | Upgrade
|
Pretax Income | 19.14 | 9.81 | -27.94 | 0.1 | -4.48 | Upgrade
|
Income Tax Expense | 4.54 | 1.58 | -4.38 | 1.51 | -1.08 | Upgrade
|
Earnings From Continuing Operations | 14.61 | 8.23 | -23.56 | -1.41 | -3.4 | Upgrade
|
Net Income | 14.61 | 8.23 | -23.56 | -1.41 | -3.4 | Upgrade
|
Net Income to Common | 14.61 | 8.23 | -23.56 | -1.41 | -3.4 | Upgrade
|
Net Income Growth | 77.53% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 28 | 28 | 28 | 24 | 24 | Upgrade
|
Shares Outstanding (Diluted) | 28 | 28 | 28 | 24 | 24 | Upgrade
|
Shares Change (YoY) | -0.66% | - | 17.55% | 2.08% | - | Upgrade
|
EPS (Basic) | 0.52 | 0.29 | -0.83 | -0.06 | -0.14 | Upgrade
|
EPS (Diluted) | 0.52 | 0.29 | -0.83 | -0.06 | -0.14 | Upgrade
|
EPS Growth | 79.31% | - | - | - | - | Upgrade
|
Free Cash Flow | 58.34 | 48.26 | -5.9 | 28.55 | 63.44 | Upgrade
|
Free Cash Flow Per Share | 2.08 | 1.71 | -0.21 | 1.19 | 2.69 | Upgrade
|
Gross Margin | 7.95% | 4.20% | 2.20% | 5.02% | 7.58% | Upgrade
|
Operating Margin | 3.80% | 0.25% | -3.98% | 0.47% | 3.34% | Upgrade
|
Profit Margin | 1.99% | 1.33% | -4.76% | -0.32% | -0.85% | Upgrade
|
Free Cash Flow Margin | 7.93% | 7.80% | -1.19% | 6.47% | 15.87% | Upgrade
|
EBITDA | 103.41 | 30.09 | 5.53 | 24.79 | 35.69 | Upgrade
|
EBITDA Margin | 14.06% | 4.87% | 1.12% | 5.62% | 8.93% | Upgrade
|
D&A For EBITDA | 75.47 | 28.54 | 25.22 | 22.73 | 22.33 | Upgrade
|
EBIT | 27.95 | 1.56 | -19.7 | 2.06 | 13.37 | Upgrade
|
EBIT Margin | 3.80% | 0.25% | -3.98% | 0.47% | 3.34% | Upgrade
|
Effective Tax Rate | 23.69% | 16.12% | - | 1568.75% | - | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.